Our study has exhibited the potential value of CTTN in predicting patient survival in subgroups with early or advanced pathological stage, suggesting that overexpression of CTTN can be used as an independent factor for prognostic prediction of ESCC. Here, CTTN is linked to esophageal squamous cell carcinoma.